Literature DB >> 3777901

Comparative pharmacokinetics of low- and high-dose ticarcillin.

B J Guglielmo, J F Flaherty, R Batman, S L Barriere, J G Gambertoglio.   

Abstract

Certain antipseudomonal penicillins, such as mezlocillin, exhibit a nonlinear pharmacokinetic disposition with increasing doses. We evaluated the effect of a single low dose (50 mg/kg) compared with a high dose (80 mg/kg) on the pharmacokinetics of ticarcillin in a crossover trial of eight healthy volunteers. No significant alteration in plasma clearance (130.1 +/- 36.5 versus 120.5 +/- 38.0 ml/min), nonrenal clearance (36.5 +/- 8.4 versus 33.4 +/- 18.5 ml/min), or volume of distribution at steady state (12.8 +/- 3.5 versus 12.3 +/- 4.5 liters) was observed between the low- and high-dose regimens, respectively. The elimination half-life remained unchanged between the two doses (67.9 +/- 14.3 versus 68.0 +/- 12.2 min). Unlike other newer antipseudomonal penicillins, ticarcillin did not display dose-dependent pharmacokinetic behavior with the range of doses used in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3777901      PMCID: PMC180559          DOI: 10.1128/AAC.30.3.359

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Nonlinear mezlocillin kinetics due to dose-dependent metabolism.

Authors:  U Gundert-Remy; R Hildebrandt; A Stiehl; E Weber
Journal:  Clin Pharmacol Ther       Date:  1983-05       Impact factor: 6.875

2.  Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin.

Authors:  H C Neu; G J Garvey
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

3.  Ticarcillin vs carbenicillin: clinical pharmacokinetics.

Authors:  R D Libke; J T Clarke; E D Ralph; R P Luthy; W M Kirby
Journal:  Clin Pharmacol Ther       Date:  1975-04       Impact factor: 6.875

Review 4.  Overview of acylureidopenicillin pharmacokinetics.

Authors:  T Bergan
Journal:  Scand J Infect Dis Suppl       Date:  1981
  4 in total
  4 in total

1.  Pharmacokinetics of ticarcillin-clavulanate in premature infants.

Authors:  Kevin M Watt; Christoph P Hornik; Stephen J Balevic; Gratias Mundakel; C Michael Cotten; Barrie Harper; Daniel K Benjamin; Ravinder Anand; Matthew Laughon; P Brian Smith; Michael Cohen-Wolkowiez
Journal:  Br J Clin Pharmacol       Date:  2019-03-06       Impact factor: 4.335

2.  Studies of interaction of a low-molecular-weight heparinoid (Org 10172) with cloxacillin and ticarcillin in healthy male volunteers.

Authors:  A de Boer; J C Stiekema; M Danhof; T G van Dinther; J K Boeijinga; A F Cohen; D D Breimer
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

3.  Pharmacokinetics of the acyclureidopenicillins piperacillin and mezlocillin in the postpartum patient.

Authors:  M G Martens; S Faro; S Feldman; D B Cotton; K Dorman; G D Riddle
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

4.  In vitro Antibacterial Activity and Resistance Prevention of Antimicrobial Combinations for Dihydropteroate Synthase-Carrying Stenotrophomonas maltophilia.

Authors:  Jin Zhao; Yan Huang; Jian Li; Bo Zhang; Zhiwei Dong; Dong Wang
Journal:  Infect Drug Resist       Date:  2022-06-13       Impact factor: 4.177

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.